$NEWP

New Pacific boosts Bolivia project value to $2.65B

New Pacific Metals updated the preliminary economic assessment for its Carangas silver-gold project in Bolivia, raising after-tax net present value to $2.65B and average annual silver-equivalent output to nearly 18M oz over 19 years. The PEA uses base prices of $45 silver and $3,400 gold, with 36% after-tax IRR and $644.5M initial capital. Shares rose 5.5% to C$5.75.

Original reporting
Published Jul 17, 2026, 8:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 17, 2026, 8:37 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
New Pacific boosts Bolivia project value to $2.65B — source image
Decision brief

The 30-second read

$NEWPBullishMed
01

Why it matters

The new PEA provides fresh, quantified economics (NPV, IRR, payback, production profile, AISC) and signals near-term catalysts (30,000-metre infill drill program, conversion of exploration licences to administrative mining contracts, and starting the environmental impact assessment).

02

Market read

A newly issued PEA with specific financial metrics can re-rate a development-stage miner, but the market will likely weigh it against Bolivia execution risk and the next permitting milestones.

03

What to watch

The article does not quantify capex changes, financing structure, or permitting timelines; traders may need to discount the PEA uplift until administrative mining contracts and the EIA process advance.

Relevance 8/10Novelty 8/10Timing: after-hours/next-session reaction to the newly issued updated PEA and guidance on next drilling and permitting steps

Background

New Pacific updated its preliminary economic assessment for the Carangas silver-gold project, incorporating higher processing throughput and a newly included gold zone versus the 2024 study.

Company-level read

Ticker impact

$NEWPBullishMedium confidence
Context

New Pacific’s updated Carangas PEA lifts after-tax NPV to $2.65B and adds a gold zone, improving project economics and development outlook.

Expected impact

Near-term upside bias for NEWP on improved project economics, with follow-through dependent on permitting and converting inferred resources.

Evidence & confidence

The article discloses a new PEA with specific financial outputs (NPV, IRR, payback, production, AISC) plus concrete next steps (infill drilling, EIA process), which are actionable for development-stage sentiment.

Market effects

Reinforces investor appetite for silver-gold development stories where updated throughput and grade zones can materially change economics.

Highlights Bolivia-specific execution risk (fuel, FX, regulatory uncertainty, permitting delays) that can cap valuation multiples despite strong technical economics.

Adds another data point to the global pipeline of undeveloped precious-metal projects, potentially influencing sentiment around silver and gold supply expectations at the margin.

Counterpoint

Even with a higher NPV, the project’s path to production is still dominated by Bolivia permitting, FX, and fuel constraints, which can overwhelm PEA improvements.

Key entities

  • New Pacific Metals

    Updated Carangas PEA with higher after-tax NPV and added gold zone; outlines next drilling and permitting steps.

  • Carangas silver-gold project

    Bolivia project whose economics were strengthened by higher processing rate and inclusion of a gold zone.

  • BMO Capital Markets (Kevin O’Halloran)

    Says the updated study meaningfully improves Carangas and reiterates an outperform rating.

  • Bolivia permitting and regulatory environment

    Fuel shortages, FX constraints, regulatory uncertainty, and permitting delays complicate mining investment.

Related articles

$BNTXMed

BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

$VOW3.DEMed

HISTORIC TURN: Volkswagen To Produce Components For Israel’s Iron Dome System In Germany

Volkswagen (VW) plans to produce components for Israel's Iron Dome missile defense system at its Osnabrück, Germany factory. The move is part of VW's restructuring efforts amid economic challenges and competition. The project involves a joint venture with Israeli defense company Rafael and the German state of Lower Saxony, aiming to overcome opposition from Qatar's sovereign wealth fund, a VW stakeholder. This marks VW's return to defense-related manufacturing as European defense spending rises.

$XOMMed

Piper Sandles Sees ExxonMobil (XOM) Heading Toward New Highs

Piper Sandler raised its price target for ExxonMobil (XOM) to $185, citing strong fundamentals, cost savings, and growth in Guyana. XOM's Q2 earnings beat expectations, with high free cash flow and shareholder returns. However, risks include exposure to Middle East conflicts and potential crude price normalization. XOM's stock has risen 30% in 2026, with a 16% upside implied by the new target.

$BKRMed

Baker Hughes (BKR) Lands Multi-Year Contract with Pakistan’s OGDC

Baker Hughes (BKR) secured a multi-year contract with Pakistan's OGDC to enhance production from mature oil and gas fields. The deal involves assessing 120 wells and providing tailored redevelopment plans. Baker Hughes aims to use AI and other technologies to improve flow assurance and restore production. The contract aligns with Baker Hughes' strategy to diversify revenue and reduce reliance on short-term drilling cycles, as evidenced by a 49% YoY increase in orders to $10.5 billion in Q2. Howe

$AAPLMed

Tim Cook Delivered a 2,720% Total Return Over 15 Years. Here's Whether John Ternus Can Do the Same for Apple Investors.

Tim Cook stepped down as Apple CEO after 15 years, delivering 2,720% total returns. New CEO John Ternus faces challenges, including margin pressure from rising memory costs. Apple is set to launch new iPhone models this week. iPhone sales grew over 20% in recent quarters, but management expects slower growth. Apple stock fell on margin concerns despite briefly surpassing $5 trillion.